Artelo Biosciences Inc — Quarterly Financial Statistics (NASDAQ:ARTL) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -2.57 M-1.6 M-514 K-3.5 M-2.91 M -8.52 M Cash from investing activities 500 K00-250 K188 K -62 K Cash from financing activities 57 K01.82 M3.44 M1.61 M 6.87 M Free cash flow -2.57 M-1.6 M-514 K-3.5 M-2.91 M -8.52 M

News

Kailera Stock (KLRA) Rockets 68% after IPO in Race for $150B Obesity Market - TipRanks.com

Artelo Biosciences Soars 230% on Obesity Push — Why Is ARTL Stock Now Crashing? - TipRanks.com

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.72%

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.64%

Artelo Biosciences implements 3-for-1 reverse stock split

Artelo Biosciences reports $12.9M loss for 2025

Artelo Biosciences adjourns annual meeting due to lack of quorum

White House launches Medicare pilot program for CBD reimbursement

Artelo’s FABP5 inhibitor shows promise for anxiety and depression

Artelo Biosciences appoints Mark Spring as new CFO

Artelo Biosciences appoints Mark Spring as CFO and amends executive agreements

Artelo Biosciences reports positive data from two clinical programs